ストックスクリーナーアプリを入手
42.25
1.83%
0.76
前日終値:
$41.49
開ける：
$44.18
24時間の取引高:
8.63M
Relative Volume:
2.01
時価総額：
$4.71B
収益：
-
当期純損益:
$-99.15M
株価収益率:
-45.43
EPS:
-0.93
ネットキャッシュフロー:
$-74.25M
1週間 パフォーマンス:
-10.16%
1か月 パフォーマンス:
-18.01%
6か月 パフォーマンス:
-16.22%
1年 パフォーマンス:
+139.78%
1日の値動き範囲:
$41.98
$45.00
1週間の範囲:
$37.80
$48.55
52週間の値動き範囲:
$17.23
$99.41
Viking Therapeutics Inc Stock (VKTX) Company Profile
名前
Viking Therapeutics Inc
セクター
電話
858-704-4660
住所
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
VKTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VKTX
Viking Therapeutics Inc
|
42.25 | 4.71B | 0 | -99.15M | -74.25M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-02 | 開始されました | Piper Sandler | Overweight |
| 2024-11-22 | 開始されました | B. Riley Securities | Buy |
| 2024-11-04 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-09-11 | 開始されました | JP Morgan | Overweight |
| 2024-06-27 | 開始されました | Morgan Stanley | Overweight |
| 2024-05-16 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-03-26 | 繰り返されました | Oppenheimer | Outperform |
| 2024-03-07 | 開始されました | Jefferies | Buy |
| 2024-02-28 | 繰り返されました | Oppenheimer | Outperform |
| 2023-05-31 | 再開されました | ROTH MKM | Buy |
| 2023-03-28 | 繰り返されました | Maxim Group | Buy |
| 2023-03-17 | 開始されました | Stifel | Buy |
| 2021-07-29 | 再開されました | BTIG Research | Buy |
| 2021-05-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2020-06-05 | 開始されました | BMO Capital Markets | Outperform |
| 2020-05-05 | 開始されました | Chardan Capital Markets | Buy |
| 2020-05-01 | 開始されました | BTIG Research | Buy |
| 2019-07-16 | 開始されました | Oppenheimer | Outperform |
| 2019-06-25 | 開始されました | Stifel | Buy |
| 2019-03-29 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-03-14 | 繰り返されました | Maxim Group | Buy |
| 2019-02-22 | 開始されました | SVB Leerink | Mkt Perform |
| 2018-12-12 | 開始されました | B. Riley FBR | Buy |
| 2018-11-19 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2018-09-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-09-18 | 繰り返されました | Maxim Group | Buy |
| 2018-09-18 | 繰り返されました | Raymond James | Outperform |
| 2018-07-20 | 開始されました | SunTrust | Buy |
| 2018-06-28 | 開始されました | Raymond James | Outperform |
| 2018-06-01 | 繰り返されました | Laidlaw | Buy |
| 2018-05-31 | 繰り返されました | Maxim Group | Buy |
| 2018-03-26 | 再開されました | H.C. Wainwright | Buy |
| 2017-11-28 | 繰り返されました | Maxim Group | Buy |
| 2017-11-21 | 開始されました | ROTH Capital | Buy |
すべてを表示
Viking Therapeutics Inc (VKTX) 最新ニュース
Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck? - MSN
Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck? - The Motley Fool
Why Viking Therapeutics (VKTX) Stock is Down Today - GuruFocus.com
Why Viking Therapeutics Tumbled by More Than 10% This Week - MSN
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up - sharewise
Viking Therapeutics (NASDAQ:VKTX) Trading 4.8% HigherStill a Buy? - MarketBeat
Looking Into Viking Therapeutics's Recent Short Interest - Benzinga
Viking Therapeutics (VKTX) Sees Surge Amid Novo Nordisk Clinical Trial Results - GuruFocus.com
Viking Therapeutics (NASDAQ:VKTX) Shares Gap UpTime to Buy? - MarketBeat
Viking Therapeutics stock surges 12% amid Novo Nordisk trial woes By Investing.com - Investing.com Canada
Here's Why VKTX Stock Plummeted 18% on Wednesday - MSN
Viking Therapeutics (NASDAQ:VKTX) Trading Up 7.2%Time to Buy? - MarketBeat
Viking Therapeutics: Competition Fears Are Exaggerated (NASDAQ:VKTX) - Seeking Alpha
Viking Therapeutics: Holiday Gift (NASDAQ:VKTX) - Seeking Alpha
Companies Like Viking Therapeutics (NASDAQ:VKTX) Can Afford To Invest In Growth - Yahoo Finance
MML Investors Services LLC Increases Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares Sold by XTX Topco Ltd - MarketBeat
Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs - AOL
Viking Therapeutics Stock Slides After Merck Strikes GLP-1 Deal With Chinese Biopharma, Retail Unperturbed - MSN
Viking Therapeutics (NASDAQ:VKTX) Trading Down 8.9%Should You Sell? - MarketBeat
Viking Plummets After Merck Inks A $2.01 Billion Obesity Deal — With Someone Else - Investor's Business Daily
Why Viking Therapeutics (VKTX), HEICO Corporation (HEI), and ABM Industries (ABM) Stocks Are Plunging Today? - Insider Monkey
Viking Therapeutics (NASDAQ:VKTX) Shares Gap DownWhat's Next? - MarketBeat
What's Going On With Viking Therapeutics Stock On Wednesday? - Yahoo Finance
Merck-Hansoh deal for oral GLP-1 hurts obesity drug developers - Seeking Alpha
Smart Money Is Betting Big In VKTX Options - Benzinga
HC Wainwright Reiterates Buy Rating for Viking Therapeutics (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics lower after Merck signs pact with Hansoh for GLP-1 drug - TipRanks
(VKTX) Proactive Strategies - Stock Traders Daily
Viking Therapeutics (NASDAQ:VKTX) Trading Up 0.6%Here's What Happened - MarketBeat
Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On. - AOL
Is Viking Therapeutics, Inc. (VKTX) the Best Weight Loss Stock to Buy Now According to Hedge Funds? - Insider Monkey
Viking Therapeutics: Caution Ahead Of Novo's CagriSema Readout (Rating Downgrade) - Seeking Alpha
Viking Therapeutics (NASDAQ:VKTX) Trading Up 2%Still a Buy? - MarketBeat
2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street - Yahoo Finance
Viking Therapeutics, Inc. (VKTX) Stock Moves -1.75%: What You Should Know - MSN
Viking Therapeutics (NASDAQ:VKTX) Trading Down 2.4%What's Next? - MarketBeat
Vestcor Inc Purchases Shares of 11,700 Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives $106.75 Average Target Price from Analysts - MarketBeat
Stifel Financial Corp Increases Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics is Now Oversold (VKTX) - Nasdaq
Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 1.8%Should You Sell? - MarketBeat
Viking Therapeutics to Participate at Upcoming Investor Conferences - The Eastern Progress Online
Viking Therapeutics to Participate at Morgan Stanley 22nd Annual Global Healthcare Conference - The Eastern Progress Online
State Street Corp Reduces Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Shares Down 2.7%Time to Sell? - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Shares Up 1.8%Still a Buy? - MarketBeat
Viking Therapeutics to Participate in Upcoming Investor Conferences and Events - Marketscreener.com
The Zacks Analyst Blog Eli Lilly, Novo Nordisk's Amgen and Viking Therapeutics - Yahoo Finance
2 'Strong Buy' Biotech Stocks With 120% or More Upside Potential - MSN
Viking Therapeutics Inc (VKTX) 財務データ
収益
当期純利益
現金流量
EPS
Viking Therapeutics Inc (VKTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| MACARTNEY LAWSON | Director |
Nov 08 '24 |
Sale |
68.67 |
2,000 |
137,333 |
47,965 |
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):